BrightGene (688166.SH)
Founded in October 2001, BrightGene Bio-Medical Technology Co.,Ltd. is a research-driven high-tech pharmaceutical company dedicated to the research and production of original new drugs and high-end generic drugs. With professional product development and commercialization capabilities, BrightGene aims to provide patients with outstanding value. With the goal of "continuous innovation, safeguarding health," BrightGene seeks solutions for unmet clinical needs. After years of continuous research and exploration, BrightGene has made breakthroughs in targeted therapy and immunotherapy for tumors, as well as in the treatment of fatty liver and diabetes, with several original drugs entering or about to enter clinical trials.
www.bright-gene.com